442 related articles for article (PubMed ID: 22250951)
41. Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial.
Derdeyn CP; Fiorella D; Lynn MJ; Barnwell SL; Zaidat OO; Meyers PM; Gobin YP; Dion J; Lane BF; Turan TN; Janis LS; Chimowitz MI;
J Neurointerv Surg; 2013 Nov; 5(6):528-33. PubMed ID: 22977278
[TBL] [Abstract][Full Text] [Related]
42. The Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis Trial: Reanalysis Using the FDA "On Label" Criteria.
Qureshi AI; Ishfaq MF; Balasetti VKS; Lobanova I; Uzun G; Siddiq F; Gomez CR
J Neuroimaging; 2020 Nov; 30(6):857-861. PubMed ID: 32705759
[TBL] [Abstract][Full Text] [Related]
43. High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis.
Kozak O; Tariq N; Suri MF; Taylor RA; Qureshi AI
Neurosurgery; 2011 Aug; 69(2):334-42; discussion 342-3. PubMed ID: 21430591
[TBL] [Abstract][Full Text] [Related]
44. Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial.
Leung TW; Yu SC; Wong KS
Int J Stroke; 2011 Aug; 6(4):312-4. PubMed ID: 21745340
[TBL] [Abstract][Full Text] [Related]
45. Intracranial atheromatous disease treatment with the Wingspan stent system: evaluation of clinical, procedural outcome and restenosis rate in a single-center series of 21 consecutive patients with acute and mid-term results.
Gandini R; Chiaravalloti A; Pampana E; Massari F; Morosetti D; Spano S; Loreni G; Simonetti G
Clin Neurol Neurosurg; 2013 Jun; 115(6):741-7. PubMed ID: 22989778
[TBL] [Abstract][Full Text] [Related]
46. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents--initial experience.
de Rochemont Rdu M; Turowski B; Buchkremer M; Sitzer M; Zanella FE; Berkefeld J
Radiology; 2004 Apr; 231(1):45-9. PubMed ID: 15068940
[TBL] [Abstract][Full Text] [Related]
47. Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis.
Yaghi S; Khatri P; de Havenon A; Yeatts S; Chang AD; Cutting S; Mac Grory B; Burton T; Jayaraman MV; McTaggart RA; Fiorella D; Derdeyn C; Zaidat OO; Dehkharghani S; Amin-Hanjani S; Furie K; Prahbakaran S; Liebeskind D
J Neurointerv Surg; 2020 Apr; 12(4):374-379. PubMed ID: 31484697
[TBL] [Abstract][Full Text] [Related]
48. Concomitant Asymptomatic Intracranial Atherosclerotic Stenosis Increase the 30-Day Risk of Stroke in Patients Undergoing Symptomatic Intracranial Atherosclerotic Stenosis Stenting.
Zhao J; Li X; Chi LX; Ma BW; Du YH; Chen GS; Zhou HD; Li JC; Jiang XJ; Yang QW; Zhao XF; Yao XF
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):479-485. PubMed ID: 29056405
[TBL] [Abstract][Full Text] [Related]
49. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis.
Lylyk P; Vila JF; Miranda C; Ferrario A; Musacchio A; Rüfenacht D; Cohen JE
Neurol Res; 2005; 27 Suppl 1():S84-8. PubMed ID: 16197831
[TBL] [Abstract][Full Text] [Related]
50. WEAVE Trial: Final Results in 152 On-Label Patients.
Alexander MJ; Zauner A; Chaloupka JC; Baxter B; Callison RC; Gupta R; Song SS; Yu W;
Stroke; 2019 Apr; 50(4):889-894. PubMed ID: 31125298
[TBL] [Abstract][Full Text] [Related]
51. Wingspan stent-assisted coiling of intracranial aneurysms with symptomatic parent artery stenosis: experience in 35 patients with mid-term follow-up results.
Gao X; Liang G; Li Z; Wei X; Wang X; Zhang H; Feng S; Lin J
Eur J Radiol; 2012 May; 81(5):e750-6. PubMed ID: 22381442
[TBL] [Abstract][Full Text] [Related]
52. Wingspan experience in the treatment of symptomatic intracranial atherosclerotic disease after antithrombotic failure.
Samaniego EA; Tari-Capone F; Linfante I; Silva CF; Spilberg G; Gounis M; Wakhloo AK; Dabus G
J Neurointerv Surg; 2013 Jul; 5(4):302-5. PubMed ID: 22544819
[TBL] [Abstract][Full Text] [Related]
53. Wingspan stent for symptomatic M1 stenosis of middle cerebral artery.
Guo XB; Ma N; Hu XB; Guan S; Fan YM
Eur J Radiol; 2011 Dec; 80(3):e356-60. PubMed ID: 21163599
[TBL] [Abstract][Full Text] [Related]
54. Technical Nuance of Sub 2-mm Middle Cerebral Artery Angioplasty and Stenting.
Kumar N; Jaurra A; Khan M; Gomez CR; Qureshi AI; Siddiq F
World Neurosurg; 2022 Nov; 167():55. PubMed ID: 35995354
[TBL] [Abstract][Full Text] [Related]
55. Angioplasty and stenting for intracranial atherosclerotic stenosis with nitinol stent: factors affecting technical success and patient safety.
Yu SC; Leung TW; Hung EH; Lee KT; Wong LK
Neurosurgery; 2012 Mar; 70(1 Suppl Operative):104-13. PubMed ID: 21849921
[TBL] [Abstract][Full Text] [Related]
56. Angioplasty with stenting for intracranial atherosclerosis: a systematic review.
Zhou Y; Yang QW; Xiong HY
J Int Med Res; 2012; 40(1):18-27. PubMed ID: 22429342
[TBL] [Abstract][Full Text] [Related]
57. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.
Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Gißler M; Noory E; Neumann FJ; Zeller T
Circulation; 2013 Jun; 127(25):2535-41. PubMed ID: 23694965
[TBL] [Abstract][Full Text] [Related]
58. Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.
Turan TN; Al Kasab S; Smock A; Cotsonis G; Bachman D; Lynn MJ; Nizam A; Derdeyn CP; Fiorella D; Janis S; Lane B; Montgomery J; Chimowitz MI;
Cerebrovasc Dis; 2019; 47(1-2):24-31. PubMed ID: 30763948
[TBL] [Abstract][Full Text] [Related]
59. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.
Kwon HM; Lynn MJ; Turan TN; Derdeyn CP; Fiorella D; Lane BF; Montgomery J; Janis LS; Rumboldt Z; Chimowitz MI;
JAMA Neurol; 2016 Jan; 73(1):36-42. PubMed ID: 26618534
[TBL] [Abstract][Full Text] [Related]
60. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).
Derdeyn CP; Fiorella D; Lynn MJ; Turan TN; Cotsonis GA; Lane BF; Montgomery J; Janis LS; Chimowitz MI;
Stroke; 2017 Jun; 48(6):1501-1506. PubMed ID: 28455321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
